Open access · CC-BY
via OpenAlex
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
International Journal of Molecular Sciences · 2021 · ▲ 245 citations
Abstract
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia). High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase colon cancer risk via the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. Hyperactivated glucose uptake and aerobic glycolysis (the Warburg effect) are considered as a one of six hallmarks of cancer, including CRC. However, the role of insulin/IGF-1 signaling during the acquisition of the Warburg metabolic phenotypes by CRC cells is still poorly understood. It most likely results from the interaction of multiple processes, directly or indirectly regulated by IGF-1, such as activation of PI3K/Akt/mTORC, and Raf/MAPK signaling pathways, activation of glucose transporters (e.g., GLUT1), activation of key glycolytic enzymes (e.g., LDHA, LDH5, HK II, and PFKFB3), aberrant expression of the oncogenes (e.g., MYC, and KRAS) and/or overexpression of signaling proteins (e.g., HIF-1, TGF-β1, PI3K, ERK, Akt, and mTOR(definition)). This review describes the role of IGF-1 in glucose metabolism in physiology and colorectal carcinogenesis, including the role of the insulin/IGF system in the Warburg effect. Furthermore, current therapeutic strategies aimed at repairing impaired glucose metabolism in CRC are indicated.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms22126434
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Kasprzak, A. (2021). Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22126434
Vancouver
Kasprzak A. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22126434.
BibTeX
@article{aldona2021Insuli,
title = {Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer},
author = {Aldona Kasprzak},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms22126434},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oncotarget 2013
Open access · CC-BY
mTOR pathway in colorectal cancer: an update
Nature Communications 2020
Open access · CC-BY
RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
Oxidative Medicine and Cellular Longevity 2018
Open access · CC-BY
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
Glucose Metabolism and Glucose Transporters in Breast Cancer
biorxiv 2024
Preprint · CC-BY
The neurohormone tyramine stimulates the secretion of an Insulin-Like Peptide from the intestine to modulate the systemic stress response in C. elegans
Aging 2014
Open access · CC-BY